Effect of Early Measles Vaccine

5 February 2018

In addition to protecting against measles, measles vaccine (MV) may have beneficial non-specific effects. We tested the effect of an additional early MV on mortality and measles antibody levels in a randomised trial of an extra dose of early measles vaccine in Burkina Faso and Guinea-Bissau.

2017 - Isaquel - two prices

27 November 2017

Two fine rewards for Isaquiel da Silva

Co-administration of BCG and DTP

31 August 2017

Co-administration of BCG and Diphtheria-tetanus-pertussis (DTP) Vaccinations May Reduce Infant Mortality More Than the WHO-schedule of BCG First and Then DTP

Effect of early measles vaccine on pneumococcal colonization

5 July 2017

Measles vaccine (MV) may have non-specific beneficial effects for child health and particularly seems to prevent respiratory infections. Streptococcus pneumoniae is the leading cause of bacterial pneumonia among children worldwide, and nasopharyngeal colonization precedes infection.

Analysis of risk factors for infant mortality in the birth cohorts in rural Guinea-Bissau

5 July 2017

Though still high, the infant mortality rate in Guinea-Bissau has declined. We aimed to identify risk factors including vaccination coverage, for infant mortality in the rural population of Guinea-Bissau and assess whether these risk factors changed from 1992-3 to 2002-3.

Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau

5 July 2017

Measles vaccination is associated with major reductions in child mortality and morbidity. In Guinea-Bissau, to limit vaccine wastage, children are only measles vaccinated if at least six children aged 9-11 months are present at a vaccination session.

Booster doses of measles vaccine associated with lower rates of hospital admission

5 July 2017

Within a randomised trial of measles vaccine (MV) at 4½ and 9 months versus at 9 months only, boosting with MV reduced the risk of hospital admissions between 9-18 months among children who had not received vitamin A at birth

Twin studies

19 June 2017

Twin commentary in Lancet Global Health

Malaria vaccine - pilot test

28 April 2017

Opinions Divide as Pilot Tests of Malaria Vaccine Loom

Peter Aaby is quoted in Financial Times.

UNICEF supports HIV studies in Bissau

26 April 2017

UNICEF Money to HIV studies in Bissau